Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance

• Autores principales: Francisca Villanueva-Flores (Autor), Andrés Zárate-Romero (Autor), Alfredo G. Torres (Autor), Alejandro Huerta-Saquero (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2021-11-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Asparaginase (ASNase) is a widely applied chemotherapeutic drug that is used to treat Acute Lymphoblastic Leukemia (ALL); however, immune responses and silent inactivation of the drug often limit its bioavailability. Many strategies have been proposed to overcome these drawbacks, including the devel...